We are live on ! Find out more
SAM

Smithbridge Asset Management Portfolio holdings

AUM $674M
1-Year Est. Return 26.11%
This Fund
S&P 500
This Quarter Est. Return
+5.98%
1 Year Est. Return
+26.11%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$119M
AUM Growth
+$8.45M
Cap. Flow
+$2.38M
Cap. Flow %
2%
Top 10 Hldgs %
35.27%
Holding
52
New
2
Increased
17
Reduced
22
Closed
1

Top Buys

Rank Stock Value
1
MET icon
MetLife
MET
+$1.82M
2
ACN icon
Accenture
ACN
+$674K
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$582K
4
SWKS icon
Skyworks Solutions
SWKS
+$404K
5
DNOW icon
DNOW Inc
DNOW
+$224K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$918K
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$670K
3
NKE icon
Nike
NKE
+$119K
4
ABBV icon
AbbVie
ABBV
+$99.7K
5
ITW icon
Illinois Tool Works
ITW
+$94.5K

Sector Composition

Rank Sector Weight
1 Technology 21.66%
2 Healthcare 15.41%
3 Energy 14.98%
4 Industrials 11.94%
5 Financials 11.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ECL icon
26
Ecolab
ECL
$76.8B
$2.29M 1.93%
20,576
-160
-0.8% -$17.1K
DE icon
27
Deere & Co
DE
$161B
$2.25M 1.89%
24,800
+1,200
+5% +$110K
ABBV icon
28
AbbVie
ABBV
$450B
$2.24M 1.89%
39,740
-1,900
-5% -$99.7K
NOV icon
29
NOV
NOV
$7.01B
$2.18M 1.84%
26,525
+879
+3% +$65.5K
ABT icon
30
Abbott
ABT
$175B
$2.08M 1.76%
50,950
+300
+0.6% +$11.8K
TJX icon
31
TJX Companies
TJX
$171B
$2.08M 1.75%
78,320
-760
-1% -$21.7K
TEVA icon
32
Teva Pharmaceuticals
TEVA
$37.3B
$2.01M 1.69%
38,340
-13,100
-25% -$670K
NVO
33
Novo Nordisk
NVO
$223B
$1.97M 1.66%
85,310
-3,300
-4% -$72.9K
MMM icon
34
3M
MMM
$83.4B
$1.7M 1.43%
14,173
– –
NKE icon
35
Nike
NKE
$64.9B
$1.66M 1.4%
42,800
-3,200
-7% -$119K
BCE icon
36
BCE
BCE
$20.4B
$1.47M 1.24%
32,500
– –
SYK icon
37
Stryker
SYK
$123B
$1.36M 1.14%
16,078
-100
-0.6% -$8.17K
SWKS icon
38
Skyworks Solutions
SWKS
$8.93B
$1.27M 1.07%
27,100
+9,600
+55% +$404K
EPD icon
39
Enterprise Products Partners
EPD
$82.6B
$1.16M 0.98%
29,702
-400
-1% -$14.8K
UL icon
40
Unilever
UL
$134B
$1.1M 0.93%
21,644
-178
-0.8% -$8.92K
FISV
41
Fiserv Inc
FISV
$27B
$1.05M 0.88%
34,700
-1,500
-4% -$44.5K
VLO icon
42
Valero Energy
VLO
$91.9B
$777K 0.66%
15,500
– –
ITW icon
43
Illinois Tool Works
ITW
$79.4B
$509K 0.43%
5,810
-1,100
-16% -$94.5K
KMP
44
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
$446K 0.38%
5,420
– –
VIG icon
45
Vanguard Dividend Appreciation ETF
VIG
$111B
$288K 0.24%
3,700
– –
GE icon
46
GE Aerospace
GE
$364B
$265K 0.22%
2,103
+52
+3% +$6.61K
EMC
47
DELISTED
EMC CORPORATION
EMC
$237K 0.2%
9,000
– –
DNOW icon
48
DNOW Inc
DNOW
$2.54B
$235K 0.2%
+6,501
New +$224K
EMR icon
49
Emerson Electric
EMR
$78.2B
$232K 0.2%
3,500
– –
FCX icon
50
Freeport-McMoran
FCX
$83.9B
$204K 0.17%
+5,600
New +$192K
1
2
3

Similar funds

RCM
Redwood Capital Management New York $674M AUM 99.78% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
DPC
Dream Peak Capital Hong Kong $675M AUM
BFA
Blueprint Financial Advisors Greensboto, North Carolina $675M AUM 24.91% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
CHCM
Columbus Hill Capital Management Short Hills, New Jersey $673M AUM 24.63% 1-Year Est. Return
REST
Retail Employees Superannuation Trust Sydney $672M AUM
MCM
Morton Capital Management Calabasas, California $672M AUM 25.22% 1-Year Est. Return

Smithbridge Asset Management's Q2 2014 Portfolio in Review

As of Q2 2014, Smithbridge Asset Management held 52 positions worth $119M, up 7.7% from $110M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Smithbridge Asset Management's Q2 2014 filing shows 2 new, 17 increased, 22 reduced and 1 closed positions. Its largest new stake was DNOW Inc: 6,501 shares worth $235K. The largest sale was Novartis, an estimated $918K.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Energy.

  • Smithbridge Asset Management's largest Q2 2014 buy was DNOW Inc: 6,501 shares worth $235K.
  • Smithbridge Asset Management added most to MetLife in Q2 2014, an estimated $1.82M increase.
  • Smithbridge Asset Management's biggest Q2 2014 reduction was Teva Pharmaceuticals, cutting an estimated $670K.
  • Smithbridge Asset Management fully exited Novartis in Q2 2014, selling an estimated $918K.
  • Smithbridge Asset Management's ten largest holdings make up 35% of its $119M portfolio in Q2 2014.
  • Smithbridge Asset Management opened 2 new positions and closed 1 in Q2 2014.
  • Smithbridge Asset Management's portfolio value rose 7.7% quarter-over-quarter to $119M.

Based on Smithbridge Asset Management's 13F filing for Q2 2014, filed 8 Aug 2014.